The World Market for Molecular Diagnostics
Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and becoming a dominant platform in clinical medicine.
From Emerging to Emergent Technology
Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. New tests are being launched all the time.
At each step of the way, Kalorama Information has reported on its progress, and in this latest market research report we look at the present state of the market, and the advances that have made DNA testing routine. Many molecular tests are CE Marked and FDA-cleared and many more are in development. The result is that molecular testing is indicated in many areas of health care.
Molecular Testing Compiled and Analyzed and Explained by a Leading Expert
Authored by lead Kalorama diagnostic analyst Shara Rosen, Kalorama Information's World Market for Molecular Diagnostics is the most comprehensive global market report available on the emergent field of molecular diagnostics.
This report covers key platforms of molecular diagnostics, including the following :
Market analysis in this report covers world markets for in vitro diagnostics, with focus on the developed areas of the globe -- North America and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases.
As part of its exhaustive coverage of nucleic acid testing, the report includes the following:
The report discusses tests and technologies that are currently available and those that are expected to take their place. Generally, current products and technologies establish the standard of care and its value to payers. Many of the assays and techniques presented in the report are expected to replace the standard of care in 2007/08, but with healthcare systems' emphasis on cost/benefit analysis for new technologies adoption, the market value and thus penetration capabilities of newer approaches may be limited.
Unsurpassed Breadth of Coverage
The information presented in this report is derived from publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and interviews with industry professionals and experts in the areas of in vitro diagnostics and molecular pathologists.
Companies profiled in this study include:
Top Companies
From Emerging to Emergent Technology
Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. New tests are being launched all the time.
At each step of the way, Kalorama Information has reported on its progress, and in this latest market research report we look at the present state of the market, and the advances that have made DNA testing routine. Many molecular tests are CE Marked and FDA-cleared and many more are in development. The result is that molecular testing is indicated in many areas of health care.
Molecular Testing Compiled and Analyzed and Explained by a Leading Expert
Authored by lead Kalorama diagnostic analyst Shara Rosen, Kalorama Information's World Market for Molecular Diagnostics is the most comprehensive global market report available on the emergent field of molecular diagnostics.
This report covers key platforms of molecular diagnostics, including the following :
- Polymerase Chain Reaction (PCR)
- Non-PCR Amplification Technologies, including:
- bDNA
- TMA
- SDA
- LIPA
- NASBA
- Invader
- Others
- In-situ Hybridization
- Sequencing
- Microarrays
- Laser Capture Microdissection (LCM) and Tissue Arrays
- Mass Spectroscopy
- Other Molecular Platforms
- Infectious Diseases (including HIV, Hepatitis GC/Chlamydia,Organism ID, MRSA, HAI et al, Mycobacteria, TB Respiratory, Others)
- Blood Screening
- Histology
- Oncology
- Prenatal
- Coagulation
- Tissue Typing
- Inherited Diseases
- Pharmacodiagnostics
Market analysis in this report covers world markets for in vitro diagnostics, with focus on the developed areas of the globe -- North America and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases.
As part of its exhaustive coverage of nucleic acid testing, the report includes the following:
- Market Sizes and Forecasts
- Profile and Assessment of Over 140 Key Competitors
- Breakout of Molecular Diagnostic Market by Region (N. America, W. Europe, Asia, ROW)
- Medical and Technological Trends
- Discussion of Globalization of Markets and Diseases
- Information on Reimbursement of New Technologies
- Review of Novel Test Platforms
- Review of New Market Developments, Such as Consumer Genomics and Testing Services
- Discussion of Market Impact of Home Brew Tests
- Discussion of Diagnostic Biomarkers and Genetic Indicators
The report discusses tests and technologies that are currently available and those that are expected to take their place. Generally, current products and technologies establish the standard of care and its value to payers. Many of the assays and techniques presented in the report are expected to replace the standard of care in 2007/08, but with healthcare systems' emphasis on cost/benefit analysis for new technologies adoption, the market value and thus penetration capabilities of newer approaches may be limited.
Unsurpassed Breadth of Coverage
The information presented in this report is derived from publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and interviews with industry professionals and experts in the areas of in vitro diagnostics and molecular pathologists.
Companies profiled in this study include:
Top Companies
- Abbott Diagnostics
- Becton, Dickinson and Company (BD)
- Beckman Coulter Inc.
- bioMerieux Inc.
- Celera
- Cepheid
- Dako A/S
- Digene Corporation
- Genomic Health
- Gen-Probe Inc.
- Genzyme Corporation
- Ortho Clinical Diagnostics (OCD)
- Qiagen N.V.
- Roche Diagnostics
- Siemens Medical Solutions Diagnostics
- Sysmex Corporation
- Ventana Medical Systems. Inc.
- 23andMe, Inc.
- 454 Life Scienczs Corporation
- AdnaGen AG
- Adnavance Technologies Inc.
- Advanced Analytical Technologies, Inc. (AATI)
- AdvanDx, Inc.
- Affymetrix
- Agendia B.V.
- Agilent Technologies Inc.
- Almac Diagnostics (formerly ArraDx)
- Althea Technologies, Inc.
- Ambry Genetics Corporation
- Arcxis Biotechnologies
- Asuragen, Inc.
- Athena Diagnostics, Inc.
- Atlas Genetics Limited
- AutoGenomics, Inc.
- AviaraDx (formerly Arcturus Biosciences)
- bcs BIOTECH S.p.A.
- BG Medicine
- Biocept, Inc.
- BioHelix Corporation
- BioNanomatrix
- Bio-Reference Laboratories, Inc. (BRLI)
- Biotage AB (formerly Pyrosequencing Technologies)
- Biotools, B & M Labs, S.A.
- BioTrove, Inc.
- China Medical Technologies, Inc.
- Clarient Inc. (formerly ChromaVision)
- Clinical Data, Inc.
- CLONDIAG chip technologies GmbH
- CombiMatrix Molecular Diagnostics (CMDX)
- Consumer Genetics
- Correlogic Systems, Inc.
- Curidium Medica Plc
- deCode Genetics Inc.
- DiaGenic ASA
- Diatherix Laboratories Inc.
- DNAFORM
- DNA Direct, Inc.
- The DNA Repair Company (DNAR)
- DxS Ltd.
- eGene Inc.
- eGenomics, Inc.
- Eiken Chemical Co., Ltd
- Enigma Diagnostics Limited
- Epigenomics AG
- Epistem Ltd.
- Eppendorf Biochip Systems GmbH
- EraGen Biosciences Inc.
- EXACT Sciences Corporation
- Exiqon A/S
- Fluidigm Corporation
- Focus Diagnostics, Inc.
- Fujifilm Diagnostics (Fujifilm GmbH)
- Gene Express, Inc.
- GeneNews Limited
- GenoID Ltd.
- Genomas
- Genoptix, Inc.
- GENPOINT AS
- Greiner Bio-One International AG
- Hain Lifescience GmbH
- Hamilton Thorne Biosciences, Inc.
- HandyLab, Inc.
- Health Discovery Corporation
- HiFi DNA Tech, LLC
- Ikonisys Inc.
- Illumina
- Immunicon Corporation
- Innogenetics NV
- InterGenetics, Inc.
- Interleukin Genetics, Inc.
- IntegraGen SA
- Invitrogen Corporation
- Ipsogen
- Iris BioTechnologies Inc.
- KREATECH Biotechnology B.V.
- Lab21 Healthcare
- Laboratory Corporation of America Holdings (LabCorp)
- Med BioGene, Inc. (MBI)
- Microchip Biotechnologies, Inc. (MBI)
- Microgen Bioproducts Ltd.
- Mobidiag Oy
- Molzym GmbH & Co. KG
- Monogram Biosciences, Inc. (formerly ViroLogic)
- Myconostica, Ltd.
- Myriad Genetics, Inc.
- Nanogen
- Nanosphere, Inc.
- Navigenics
- NeuroMark
- NorDiag ASA
- Novartis Vaccines and Diagnostics/Chiron
- Nuvera Biosciences
- OncoMethylome Sciences S.A.
- Orchid Cellmark
- Orion Genomics
- Osmetech plc
- Pacific Biosciences of California, Inc. (PacBio)
- ParagonDx LLC
- Pathwork Diagnostics (formerly Predicant Biosciences)
- Perceptronix Medical Inc.
- PerkinElmer, Inc.
- Prediction Sciences
- Prodesse, Inc.
- Progenika Biopharma
- Psynomics Incorporated
- Q Chip Ltd.
- Quest Diagnostics Incorporated
- Rosetta Genomics Ltd.
- Seegene, Inc.
- SensiGen LLC
- Sequenom, Inc.
- SIRS-Lab
- Smart Genetics
- Tepnel Life Sciences
- TessArae, LLC
- TheraGenetics, Limited
- Third Wave Technologies Inc.
- Transgenomic Inc.
- TrimGen Corporation
- Veredus Laboratories Pte Ltd.
- Veridex, LLC
- Vita Genomics
- Xceed Molecular
- XDx Inc.
- Xenomics, Inc.
- Zila, Inc.
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER TWO: TECHNOLOGICAL TRENDS
CHAPTER THREE: MEDICAL TRENDS AND MARKET ISSUES
CHAPTER FOUR: TECHNOLOGICAL TRENDS THAT ENABLE THE FUTURE OF MOLECULAR DIAGNOSTICS
CHAPTER FIVE: PLATFORMS AT THE FOREFRONT OF MOLECULAR ASSAYS
CHAPTER SIX: MARKET ANALYSIS
CHAPTER SEVEN: MAJOR VENDORS AND COMPANIES TO WATCH
CHAPTER EIGHT: CONCLUSIONS AND STRATEGIC IMPLICATIONS
CHAPTER NINE: MAJOR VENDORS AND COMPANIES TO WATCH
- Introduction
- Scope and Methodology
- Size and Growth of the Market
- Market Trends
- Regulatory Issues and Molecular Tests
- The Promise of Companion Diagnostics
- From Research to Clinic
- Test Services
CHAPTER TWO: TECHNOLOGICAL TRENDS
- Background
- The In Vitro/In Vivo Mix
- Miniaturization and Multiplexed Biological Assays
- The search for Non-Invasive Tools
- Mechanisms of Gene Modification, Regulation and Expression
- Methylated Gene (meDNA) Patterns
- RNA - Ribonucleic Acid
- Transcription Factors
- Circulating Cell-free Nucleic Acids
- Sample Preparation and System Automation
- PCR Patent Update
CHAPTER THREE: MEDICAL TRENDS AND MARKET ISSUES
- Background
- New Testing Opportunities - Genes and Proteins
- Reimbursement of Novel Tests
- Medicare and Medicaid
- HMOs and Managed Care
- GTE Subscription Based Model
- Commercializing Molecular Diagnostics
- Increasing Efficiency
- Successful Patents
- Lab-Developed Test Services
- Regulatory Issues and Molecular Tests
- The Promise of Companion Diagnostics
- From Research to Clinic
- Test Services
CHAPTER FOUR: TECHNOLOGICAL TRENDS THAT ENABLE THE FUTURE OF MOLECULAR DIAGNOSTICS
- Background
- The In Vitro/In Vivo Mix
- Miniaturization and Multiplexed Biological Assays
- Microfluidic Devices
- Bead-Based Technologies
- The Search For Non-Invasive Tools
- Breath
- Hair
- Serum
- Mechanisms of Gene Modification, Regulation and Expression
- Methylated Gene (meDNA) Patterns
- RNA - Ribonucleic Acid
- Transcription Factors
- Circulating Cell-free Nucleic Acids
- Sample Preparation and System Automation
- Homebrew Reagents
- DNA Test Sample Preparation Market
- PCR Patent Update
CHAPTER FIVE: PLATFORMS AT THE FOREFRONT OF MOLECULAR ASSAYS
- Background
- Components of DNA tests
- Molecular Test Platforms Market Overview
- Polymerase Chain Reaction (PCR)
- Non-PCR Amplification Technologies
- Miniaturized Platforms - Arrays and Biochips
- Mass Spectroscopy
- Laser Capture Microdissection (LCM) and Tissue Arrays
- TMAs
CHAPTER SIX: MARKET ANALYSIS
- Worldwide Opportunities for Molecular Tests
- The United States
- Europe
- China
- Molecular Diagnostics And Target Markets
- The Market for Molecular Assays in Cancer Management
- CUP/TUO
- Herceptin
- The Market for Molecular Assays In Hematology
- Towards Routine Hematology Testing
- The Market For Molecular Assays in Coagulation
- Procoagulation and Thrmobolytic Markers
- Warfarin
- The Market For Molecular Assays in Histopathology/Cytology
- Overview
- The Future of the Pap Smear & HPV Testing
- In Situ Hybridization and Digital Cytometry
- Microscopy
- The Market for Molecular Assays in Microbiology/Virology
- HIV
- STDs
- Hospital Acquired Infections (HAIs)
- Respiratory Viruses
- The Market for Molecular Assays in Blood Transfusion Medicine
- Transfusion Statistics
- Trends in Transfusion Medicine
- Blood Screening Markets
- PROCLEIX
- The Market for Molecular Assays in Tissue Transplant Management
- The Market for Molecular Assays in Prenatal and Neonatal Testing
- Prental Carrier and Fetus Screening Market
- FISH Assays
- PAP Assays
- IVF Fertilization Procedure Testing
- The Market for Molecular Assays for Inherited Diseases
- Pharmacodiagnostic Test Applications
CHAPTER SEVEN: MAJOR VENDORS AND COMPANIES TO WATCH
- Company Triage
- The Majors
- The Stars
- Participants
- Newcomers
- 2012 and Beyond
- Acquisitions, Alliances and Collaborations in Molecular Diagnostics
CHAPTER EIGHT: CONCLUSIONS AND STRATEGIC IMPLICATIONS
- Conclusion One
- Implication
- Implication
- Implication
- Implication
- Implication
- Implication
CHAPTER NINE: MAJOR VENDORS AND COMPANIES TO WATCH
- Top Companies
- Abbott Diagnostics
- Revenues
- Key Comment
- Details
- Becton, Dickinson and Company (BD)
- Revenues
- Key Comment
- Details
- Beckman Coulter Inc.
- Revenues
- Key Comment
- Details
- bioMerieux Inc.
- Revenues
- Key Comment
- Details
- Celera
- Revenues
- Key Comment
- Details
- Cepheid
- Revenues
- Key Comment
- Details
- Dako A/S
- Revenues
- Key Comment
- Details
- Digene Corporation
- Revenues
- Key Comment
- Details
- Genomic Health
- Revenues
- Key Comment
- Details
- Gen-Probe Inc.
- Revenues
- Key Comment
- Details
- Genzyme Corporation
- Revenues
- Key Comment
- Details
- Ortho Clinical Diagnostics (OCD)
- Revenues
- Key Comment
- Details
- Qiagen N.V.
- Revenues
- Key Comment
- Details
- Roche Diagnostics
- Revenues
- Key Comment
- Details
- Siemens Medical Solutions Diagnostics
- Revenues
- Key Comment li>Details
- Sysmex Corporation
- Revenues
- Key Comment
- Details
- Ventana Medical Systems. Inc.
- Revenues
- Key Comment
- Details
- 23andMe, Inc.
- Revenues
- Key Comment
- Details
- 454 Life Sciences Corporation
- Revenues
- Key Comment
- Details
- AdnaGen AG
- Revenues
- Key Comment
- Details
- Adnavance Technologies Inc.
- Revenues
- Key Comment
- Details
- Advanced Analytical Technologies, Inc. (AATI)
- Revenues
- Key Comment
- Details
- AdvanDx, Inc.
- Revenues
- Key Comment
- Details
- Affymetrix
- Revenues
- Key Comment
- Details
- Agendia B.V.
- Revenues
- Key Comment
- Details
- Agilent Technologies Inc.
- Revenues
- Key Comment
- Details
- Almac Diagnostics (formerly ArraDx)
- Revenues
- Key Comment
- Details
- Althea Technologies, Inc.
- Revenues
- Key Comment
- Details
- Ambry Genetics Corporation
- Revenues
- Key Comment
- Details
- Arcxis Biotechnologies
- Revenues
- Key Comment
- Details
- Asuragen, Inc.
- Revenues
- Key Comment
- Details
- Athena Diagnostics, Inc.
- Revenues
- Key Comment
- Details
- Atlas Genetics Limited
- Revenues
- Key Comment
- Details
- AutoGenomics, Inc.
- Revenues
- Key Comment
- Details
- AviaraDx (formerly Arcturus Biosciences)
- Revenues
- Key Comment
- Details
- bcs BIOTECH S.p.A.
- Revenues
- Key Comment
- Details
- BG Medicine
- Revenues
- Key Comment
- Details
- Biocept, Inc.
- Revenues
- Key Comment
- Details
- BioHelix Corporation
- Revenues
- Key Comment
- Details
- BioNanomatrix
- Revenues
- Key Comment
- Details
- Bio-Reference Laboratories, Inc. (BRLI)
- Revenues
- Key Comment
- Details
- Biotage AB (formerly Pyrosequencing Technologies)
- Revenues
- Key Comment
- Details
- Biotools, B & M Labs, S.A.
- Revenues
- Key Comment
- Details
- BioTrove, Inc.
- Revenues
- Key Comment
- Details
- China Medical Technologies, Inc.
- Revenues
- Key Comment
- Details
- Clarient Inc. (formerly ChromaVision)
- Revenues
- Key Comment
- Details
- Clinical Data, Inc.
- Revenues
- Key Comment
- Details
- CLONDIAG chip technologies GmbH
- Revenues
- Key Comment
- Details
- CombiMatrix Molecular Diagnostics (CMDX)
- Revenues
- Key Comment
- Details
- Consumer Genetics
- Revenues
- Key Comment
- Details
- Correlogic Systems, Inc.
- Revenues
- Key Comment
- Details
- Curidium Medica Plc
- Revenues
- Key Comment
- Details
- deCode Genetics Inc.
- Revenues
- Key Comment
- Details
- DiaGenic ASA
- Revenues
- Key Comment
- Details
- Diatherix Laboratories Inc.
- Revenues
- Key Comment
- Details
- DNAFORM
- Revenues
- Key Comment
- Details
- DNA Direct, Inc.
- Revenues
- Key Comment
- Details
- The DNA Repair Company (DNAR)
- Revenues
- Key Comment
- Details
- DxS Ltd.
- Revenues
- Key Comment
- Details
- eGene Inc.
- Revenues
- Key Comment
- Details
- eGenomics, Inc.
- Revenues
- Key Comment
- Details
- Eiken Chemical Co., Ltd
- Revenues
- Key Comment
- Details
- Enigma Diagnostics Limited
- Revenues
- Key Comment
- Details
- Epigenomics AG
- Revenues
- Key Comment
- Details
- Epistem Ltd.
- Revenues
- Key Comment
- Details
- Eppendorf Biochip Systems GmbH
- Revenues
- Key Comment
- Details
- EraGen Biosciences Inc.
- Revenues
- Key Comment
- Details
- EXACT Sciences Corporation
- Revenues
- Key Comment
- Details
- Exiqon A/S
- Revenues
- Key Comment
- Details
- Fluidigm Corporation
- Revenues
- Key Comment
- Details
- Focus Diagnostics, Inc.
- Revenues
- Key Comment
- Details
- Fujifilm Diagnostics (Fujifilm GmbH)
- Revenues
- Key Comment
- Details
- Gene Express, Inc.
- Revenues
- Key Comment
- Details
- GeneNews Limited
- Revenues
- Key Comment
- Details
- GenoID Ltd.
- Revenues
- Key Comment
- Details
- Genomas
- Revenues
- Key Comment
- Details
- Genoptix, Inc.
- Revenues
- Key Comment
- Details
- GENPOINT AS
- Revenues
- Key Comment
- Details
- Greiner Bio-One International AG
- Revenues
- Key Comment
- Details
- Hain Lifescience GmbH
- Revenues
- Key Comment
- Details
- Hamilton Thorne Biosciences, Inc.
- Revenues
- Key Comment
- Details
- HandyLab, Inc.
- Revenues
- Key Comment
- Details
- Health Discovery Corporation
- Revenues
- Key Comment
- Details
- HiFi DNA Tech, LLC
- Revenues
- Key Comment
- Details
- Ikonisys Inc.
- Revenues
- Key Comment
- Details
- Illumina
- Revenues
- Key Comment
- Details
- Immunicon Corporation
- Revenues
- Key Comment
- Details
- Innogenetics NV
- Revenues
- Key Comment
- Details
- InterGenetics, Inc.
- Revenues
- Key Comment
- Details
- Interleukin Genetics, Inc.
- Revenues
- Key Comment
- Details
- IntegraGen SA
- Revenues
- Key Comment
- Details
- Invitrogen Corporation
- Revenues
- Key Comment
- Details
- Ipsogen
- Revenues
- Key Comment
- Details
- Iris BioTechnologies Inc.
- Revenues
- Key Comment
- Details
- KREATECH Biotechnology B.V.
- Revenues
- Key Comment
- Details
- Lab21 Healthcare
- Revenues
- Key Comment
- Details
- Laboratory Corporation of America Holdings (LabCorp)
- Revenues
- Key Comment
- Details
- Med BioGene, Inc. (MBI)
- Revenues
- Key Comment
- Details
- Microchip Biotechnologies, Inc. (MBI)
- Revenues
- Key Comment
- Details
- Microgen Bioproducts Ltd.
- Revenues
- Key Comment
- Details
- Mobidiag Oy
- Revenues
- Key Comment
- Details
- Molzym GmbH & Co. KG
- Revenues
- Key Comment
- Details
- Monogram Biosciences, Inc. (formerly ViroLogic)
- Revenues
- Key Comment
- Details
- Myconostica, Ltd.
- Revenues
- Key Comment
- Details
- Myriad Genetics, Inc.
- Revenues
- Key Comment
- Details
- Nanogen
- Revenues
- Key Comment
- Details
- Nanosphere, Inc.
- Revenues
- Key Comment
- Details
- Navigenics
- Revenues
- Key Comment
- Details
- NeuroMark
- Revenues
- Key Comment
- Details
- NorDiag ASA
- Revenues
- Key Comment
- Details
- Novartis Vaccines and Diagnostics/Chiron
- Revenues
- Key Comment
- Details
- Nuvera Biosciences
- Revenues
- Key Comment
- Details
- OncoMethylome Sciences S.A.
- Revenues
- Key Comment
- Details
- Orchid Cellmark
- Revenues
- Key Comment
- Details
- Orion Genomics
- Revenues
- Key Comment
- Details
- Osmetech plc
- Revenues
- Key Comment
- Details
- Pacific Biosciences of California, Inc. (PacBio)
- Revenues
- Key Comment
- Details
- ParagonDx LLC
- Revenues
- Key Comment
- Details
- Pathwork Diagnostics (formerly Predicant Biosciences)
- Revenues
- Key Comment
- Details
- Perceptronix Medical Inc.
- Revenues
- Key Comment
- Details
- PerkinElmer, Inc.
- Revenues
- Key Comment
- Details
- Prediction Sciences
- Revenues
- Key Comment
- Details
- Prodesse, Inc.
- Revenues
- Key Comment
- Details
- Progenika Biopharma
- Revenues
- Key Comment
- Details
- Psynomics Incorporated
- Revenues
- Key Comment
- Details
- Q Chip Ltd.
- Revenues
- Key Comment
- Details
- Quest Diagnostics Incorporated
- Revenues
- Key Comment
- Details
- Rosetta Genomics Ltd.
- Revenues
- Key Comment
- Details
- Seegene, Inc.
- Revenues li>Key Comment
- Details
- SensiGen LLC
- Revenues
- Key Comment
- Details
- Sequenom, Inc.
- Revenues
- Key Comment
- Details
- SIRS-Lab
- Revenues
- Key Comment
- Details
- Smart Genetics
- Revenues
- Key Comment
- Details
- Tepnel Life Sciences
- Revenues
- Key Comment
- Details
- TessArae, LLC
- Revenues
- Key Comment
- Details
- TheraGenetics, Limited
- Revenues
- Key Comment
- Details
- Third Wave Technologies Inc.
- Revenues
- Key Comment
- Details
- Transgenomic Inc.
- Revenues
- Key Comment
- Details
- TrimGen Corporation
- Revenues
- Key Comment
- Details
- Veredus Laboratories Pte Ltd.
- Revenues
- Key Comment
- Details
- Veridex, LLC
- Revenues
- Key Comment
- Details
- Vita Genomics
- Revenues
- Key Comment
- Details
- Xceed Molecular
- Revenues
- Key Comment
- Details
- XDx Inc.
- Revenues
- Key Comment
- Details
- Xenomics, Inc.
- Revenues
- Key Comment
- Details
- Zila, Inc.
- Revenues
- Key Comment
- Details
- Other Participants
Other Companies
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER TWO: INTRODUCTION
CHAPTER THREE: TECHNOLOGY PLATFORMS
CHAPTER FOUR: TECHNOLOGICAL TRENDS THAT ENABLE THE FUTURE OF MOLECULAR DIAGNOSTICS
TECHNOLOGY PLATFORMS AT THE FOREFRONT OF MOLECULAR ASSAYS
CHAPTER SIX: MARKET ANALYSIS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: Exchange Rate Fluctuations, 2003-2007
- Table 1-2: Worldwide Molecular Test Sales, 2007-2012
- Table 1-3: Market Penetration Of Clinical Molecular Diagnostics, by Geographic Area (North America, EU Europe, Japan, ROW)
CHAPTER TWO: INTRODUCTION
- Table 2-1: Selected Events in the Evolution of DNA Testing
CHAPTER THREE: TECHNOLOGY PLATFORMS
- Table 3-1: Selected Platforms for Multiplexed Nucleic Acids and Proteins
- Table 3-2: Selected SNP - Drug Interactions
- Table 3-3: Selected Molecular Test Services Available in 2008
CHAPTER FOUR: TECHNOLOGICAL TRENDS THAT ENABLE THE FUTURE OF MOLECULAR DIAGNOSTICS
- Table 4-1: Selected Multiplexed Molecular Assays, 2008
- Table 4-2: Selected Multiplexed Molecular Assays, 2008
- Table 4-3: Selected Methylated DNA Tests
- Table 4-4: Selected RNA-based Cancer Tests
- Table 4-5: Selected Nucleic Acid Sample Preparation Products
TECHNOLOGY PLATFORMS AT THE FOREFRONT OF MOLECULAR ASSAYS
- Table 5-1: Market Potential Of Key Clinical Molecular Platforms, 2008
- Table 5-2: Molecular Test Product Sales, Worldwide, by Platform, 2007
- Table 5-3: Selected Companies With PCR-Based Products
- Table 5-4: Non-PCR Molecular Tests Sales, Worldwide, by Platform, 2007(bDNA, TMA, SDA, LIPA, NASBA, Invader, Others)
- Table 5-5: Selected Non-PCR Molecular Platforms (Company, Location, Platform/Technology)
- Table 5-6: Selected New Molecular Test Platforms
- Table 5-7: Major Microfluidics Companies
- Table 5-8: Major Molecular Markers For Tissue Staining
- Table 5-9: Selected In Situ Hybridization Innovation
- Table 5-10: Selected LCM Systems on the Market, 2008
CHAPTER SIX: MARKET ANALYSIS
- Table 6-1: Worldwide Molecular Test Sales, 2007-2012
- Table 6-2: Breakdown Of Home-Brew Molecular Diagnostic Tests, 2007 (Test Type, % Number of Tests)
- Table 6-3: Market Penetration Of Clinical Molecular Diagnostics, by Geographic Area (North America, EU Europe, Japan, ROW)
- Table 6-4: Average Cost Of Selected Genetic Test Services, U.S.
- Table 6-5: Selected Reference Lab and IVD Company Collaborations
- Table 6-6: Selected IVD Cancer Markers used in Tissue Analysis
- Table 6-7: Selected Molecular Tests for Coagulation Testing (Company, Location, Details, Test, Status)
- Table 6-8: Selected Advanced HPV Tests, 2006-2008 (Company, Location, Test, Status)
- Table 6-9: Selected Microscopy and Image Analysis Products
- Table 6-10: Molecular Test Sales, Infectious Diseases, 2007-2012 (Company, Location, Details, Status)
- Table 6-11: Selected Infectious Disease Molecular Test Products, 2006-2008 (Company, Location, Details, Status)
- Table 6-13: Most Frequently Requested Genetic Tests
- Table 6-14: Selected Molecular Tests for Inherited Diseases (Company, Location, Details, Status)
